Phase 2 trial of erlotinib with or without PF-3512676 (CPG 7909, a Toll-like receptor 9 agonist) in patients with advanced recurrent EGFR-positive non-small cell lung cancer

Chandra P. Belani, John J. Nemunaitis, Abraham Chachoua, Peter D. Eisenberg, Luiz E. Raez, J. Daniel Cuevas, Cecile B. Mather, Rebecca J. Benner, Sandra J. Meech

Research output: Contribution to journalArticlepeer-review

35 Scopus citations

Fingerprint

Dive into the research topics of 'Phase 2 trial of erlotinib with or without PF-3512676 (CPG 7909, a Toll-like receptor 9 agonist) in patients with advanced recurrent EGFR-positive non-small cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences